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ABSTRACT 
Background: Plant proteins are well-known precursors of bioactive peptides. In translating the 
peptides into functional foods, the protein sources need to be sustainable and readily available. 
Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) is the major enzyme in 
photosynthesis and photorespiration in plants and some other organisms, and is known to be the 
most abundant protein on earth. Therefore, RuBisCO is an attractive and sustainable source of 
bioactive peptides. 
Scope and approach: This review discusses the structure, function, composition and technology 
for plant RuBisCO extraction, as well as the fractionation and known bioactivities of its 
enzymatic hydrolysate and peptides. Feasibility of industrial scale up and practical application of 
the RuBisCO peptides in food were also considered. 
Key findings and conclusions: Several processes are available for extraction of the RuBisCO 
subunits and some are simple, fast and adaptable for industrial scale production. Work is 
however needed on recovery of high protein yields with high purity. Most studies reported that 
peptides, mostly from the large subunit, from enzymatic hydrolysis of spinach or alfalfa 
RuBisCO possess antihypertensive, opioid-like, secretagogue and food intake stimulating, 
antioxidant and antimicrobial activities. These properties demonstrate that RuBisCO can be 
utilized as a sustainable source of peptides with multiple bioactivities for formulation of 
functional foods. 
 
Keywords: RuBisCO, Peptides; Antihypertensive; Antioxidant; Opioid activity; Antidiabetic; 
Antimicrobial peptide 
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1. Introduction 
The quest for natural and health-promoting compounds has led to increased exploration of food 
materials as sources of functional ingredients. Several studies in recent years have highlighted 
the health sustaining properties of food-derived prebiotic oligosaccharides, bioactive peptides, 
lipids and phytochemicals (Ale, Mikkelsen, & Meyer, 2011; McClements, Decker, & Park, 2009; 
Udenigwe & Aluko, 2012; Maestri, Marmiroli, & Marmiroli, 2016; Rizzello et al., 2016). 
Notably, bioactive proteins and peptides are emerging at the forefront of functional food trends 
and potentially marketable bioactive products. In general, sales of peptide-based drugs were 
valued at about $20 billion and account for about 2% in annual sales of the global drug market 
(Sun, 2013). Such peptides are typically produced by bottom-up rational design and chemical 
synthesis or through heterologous expression and secretion in microbial systems. On the other 
hand, a top-down approach often applied in food research involves using proteins of plants, 
marine or animal origins as precursors of bioactive peptides (Korhonen & Pihlanto, 2006; Ejike 
et al., 2017; Korhonen, Pihlanto-Leppäla, Rantamäki, & Tuomo, 1998; Korhonen & Pihlanto, 
2003; Maestri et al., 2016). Based on this approach, proteins from milk, fish, meat and egg are 
commonly used as animal sources of bioactive peptides, whereas cereals, oilseeds, legumes and 
vegetable proteins are the popular plant-based sources. Notably, these sources of bioactive 
peptides are also primary dietary protein sources in different populations of the world. 
Bioactive peptides are inactive within their parent protein structures until they are released 
by the action of endogenous or exogenous proteolytic enzymes, or by microbial fermentation 
(Udenigwe & Aluko, 2012; Maestri et al., 2016; Rizzello et al., 2016). The peptides possess 
disease preventive and health management properties that include antihypertensive 
(Martínez-Maqueda, Miralles, Recio, & Hernández-Ledesma, 2012) antidiabetic (Nongonierma 
& FitzGerald, 2016), antioxidative (Samaranayaka & Li-Chan, 2011), anticancer (Rajendran, 
Ejike, Gong, Hannah, & Udenigwe, 2017), opioid-like (Teschemacher, 2003), anti-inflammatory 
(Chakrabarti, Jahandideh, & Wu, 2014), hypolipidemic (Howard & Udenigwe, 2013) and 
antimicrobial activities (Haque & Chand, 2008). There has been a slow progress in the 
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translation of laboratory results on bioactive peptides into commercial functional food products. 
Industrial-scale production of the peptides is expected to increase especially with the availability 
of new and emerging processing technologies. Despite the progress, some factors are perceived 
as impediments to the translation of bioactive peptides into functional foods. These limitations 
include bitterness of some peptides, food matrix-peptide interactions, low peptide bioavailability, 
limited human studies, lack of a consensus on their molecular mechanisms, low peptide yields, 
and sustainability of their protein sources (Udenigwe, 2014; Li-Chan, 2015). Sustainability 
becomes very important since the use of food proteins for bioactive peptides production can lead 
to competition with human food resources with negative impact on food security, especially in 
developing countries. This paper addresses the latter by discussing efforts on the exploration of 
widely available natural proteins as precursors for bioactive peptides. 
Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) is a bifunctional multimeric 
plant metabolic enzyme that participates in carbon fixation in the Calvin cycle and 
photorespiration, depending on its affinity for carbon dioxide or molecular oxygen (Barbeau & 
Kinsella, 1988). The enzyme constitutes about 50% of soluble proteins in the plant leaf and is 
identified as the most abundant protein on earth (Andersson & Backlund, 2008). Despite its 
abundance in nature, RuBisCO remains underutilized as a protein in industrial food formulations 
(Kobbi et al., 2017), even after its functionalities and prospective food applications were 
highlighted three decades ago (Barbeau & Kinsella, 1988). This slow progress is likely due to 
technological challenges associated with plant RuBisCO extraction or their low yield on a leaf 
weight basis, since 90% of green leaf is water. Emerging trend is now looking into converting 
non-edible and food waste vegetables into soluble protein isolates for food applications. These 
proteins are expected to be comprised mostly of RuBisCO. Apart from direct utilization as 
dietary source of amino acids in food products, one notable application explored for RuBisCO is 
its use as a sustainable source of bioactive peptides. As discussed later in this paper, 
RuBisCO-derived peptides have demonstrated beneficial effects for health promotion in vitro, in 
cultured cells and animal models. Moreover, bioinformatics has revealed several untapped 
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peptides, most of which can be released from the large and small RuBisCO subunits by specific 
enzymatic proteolysis. These unexplored peptides can play several biological roles for the 
prevention and management of cardiovascular diseases, diabetes, immune and neurodegenerative 
diseases. The objective of this review is to discuss the structure, function, composition and 
technology for plant RuBisCO extraction as well as the fractionation and known bioactivities of 
its enzymatic hydrolysate and peptides for use in various food and health applications. 
 
2. Structure and function of RuBisCO 
RuBisCO is a major enzyme that catalyzes the first step of carbon dioxide fixation in net 
photosynthesis and carbon oxidation during photorespiration. Its primary role is the conversion 
of carbon dioxide from the biosphere into organic compounds in the rate-limiting step of the 
Calvin cycle (Spreitzer & Salvucci, 2002). This is achieved through the carboxylation of 
ribulose-1,5-bisphosphate to produce two molecules of 3-phosphoglycerate (Andersson & 
Backlund, 2008). The affinity of RuBisCO for carbon dioxide favours its carbon fixation 
catalytic activity. However, this is impeded by its affinity for molecular oxygen resulting in 
photorespiration. This process slows down the catalytic activity of carbon dioxide fixation and 
decreases the activity by 50%; thus, RuBisCO is often referred to as an inefficient enzyme 
(Andersson & Backlund, 2008; Spreitzer & Salvucci, 2002). Consequently, photosynthetic 
organisms produce RuBisCO in large amounts in order to meet their metabolic needs, and it is 
estimated to make up over 50% of the total amounts of soluble proteins in the plant leaf 
(Spreitzer & Salvucci, 2002).  
RuBisCO is a large multimeric protein with a molecular weight of 560 kDa and is found in 
all photosynthetic, chlorophyll-containing organisms including higher plants, green and 
blue-green algae, chemolithotrophic bacteria, green sulphur and purple non-sulphur bacteria 
(Barbeau & Kinsella, 1988; Kobbi et al., 2017). Form I holoenzymes are the most common form 
of RuBisCO found in land plants and green algae (Andersson & Backlund, 2008; Spreitzer & 
Salvucci, 2002). They possess a hexadecameric structure consisting of eight large and eight 
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small subunits, L8S8, which exhibit 422 local symmetry (Andersson & Backlund, 2008). Form II 
RuBisCO proteins are dimeric, possess two large subunits and lack the small subunits. They are 
found in some prokaryotes and dinoflagellates including purple non-sulphur and 
chemoautotrophic bacteria (Andersson & Backlund, 2008; Morse, Salois, Markovic, & Hastings, 
1995; Tabita, 1999; Whitney & Andrews, 1998). On the other hand, RuBisCO in archaebacteria 
consists of a decamer with five large subunit dimers (Maeda et al., 1999). 
 
3. Chemical composition and physicochemical properties of RuBisCO 
The composition and sequence of large RuBisCO subunits from different plants are highly 
conserved, whereas there are notable differences in the small subunits. RuBisCO derived from 
spinach (Spinacia oleracea) and alfalfa (Medigaco sativa) have particularly been used to produce 
bioactive peptides and hydrolysates. The structure of spinach RuBisCO showing the large and 
small subunits is provided in Fig. 1. The sequence of the large subunits is identical across 
different plant species. Using UniProtKB Align, the polypeptide chains of the large RuBisCO 
subunit obtained from spinach, alfalfa and sunflower (Helianthus annuus) containing 473, 472 
and 483 amino acid residues, respectively, showed 89.5% sequence homology and 434 identical 
positions. Conversely, the small subunits of plant RuBisCO contain about 123 amino acid 
residues with less sequence homology; using the example above, 41.6% homology and 75 
identical positions were observed for the small chain. RuBisCO has a net negative charge at 
neutral pH with isoelectric point (pI) of 4.4-4.7, for spinach, maize, cotton and tobacco RuBisCO, 
and a large charge/mass ratio that promotes its tendency to bind cations (Barbeau & Kinsella, 
1988). The protein is hydrophobic with a relative hydrophobicity value of about 1,275 
cal/residue (Barbeau & Kinsella, 1988). From calculated values of the grand average of 
hydropathicity (GRAVY), alfalfa RuBisCO large subunit is more hydrophobic than the small 
subunit due to its higher total hydrophobic amino acid content (Table 1). Native alfalfa RuBisCO 
contains one free sulfhydryl group per protomer and others localized within the structure in the 
form of disulphide bridges (Barbeau & Kinsella, 1988). The predominant amino acid residues in 
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alfalfa RuBisCO include alanine (A), glycine (G) and leucine (L) for the large subunit, and 
glutamate (E) and leucine (L) for the small subunit (Table 1). The preponderance of hydrophobic 
amino acids makes RuBisCO attractive for some food applications, particularly as a starting 
material for producing hydrophobic bioactive peptides. 
 
4. Technologies for RuBisCO extraction 
Food-grade proteins are mainly derived from their natural sources or from animal-based or 
microbial systems, where animal cells or microbes are cultivated in fermenters (Twyman, 
Schillberg, & Fischer, 2005). Protein extractions from animal and microbe-based systems is 
typically not laborious especially with the direct secretion of the proteins into growth media. 
Conversely, the extraction of plant proteins such as RuBisCO often requires maceration to 
breakdown the plant cell wall and the addition of protease inhibitors during extraction to reduce 
RuBisCO degradation. These processes constitute laborious steps, which are perceived as 
drawbacks in the extraction of plant proteins intended for use in food formulation. Furthermore, 
the extracted RuBisCO often contains chlorophyll, which leaves a lingering greenish colour on 
the final protein product. This limits the wider use of the protein extracts in the food industry 
(van de Velde, Alting, & Pouvreau, 2011a) since the green colour can affect consumer 
acceptability of food products. Despite these perceived drawbacks, the interest in extracting 
plant-based proteins is on the rise due to some of its advantages over animal and microbial 
proteins. Safety is of a major concern when selecting the source of proteins used in food 
applications. Based on this, plant systems are considered safe, cheaper to maintain and upscaling 
of production is easier when compared to animal and microbial systems (Buyel, Twyman, & 
Fischer, 2015; Sabalza, Christou, & Capell, 2014). Nevertheless, the challenges of high-yield 
extraction and recovery of plant-based proteins from their food matrices still exist. 
There has been promising development in food-grade extraction technologies for RuBisCO 
and other plant proteins. Extraction of plant proteins is often undertaken using standard 
methodologies (Fig. 2). These include precipitation with salt (e.g. ammonium sulphate) or 
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solvent (e.g. acetone), followed by polishing steps involving combinations of chromatographic 
techniques such as ion-exchange, hydrophobic interaction, gel filtration, and affinity 
chromatography using immobilized antibody against RuBisCO (Kim et al., 2013; Warren, 
Adams, & Chen, 2000; Weaver, 2010). As with other proteins, electrophoretic techniques such 
as sodium dodecyl sulfate-polyacrylamide gel and capillary electrophoresis have also been used 
in separating and visualizing the two subunits of RuBisCO. Often, purification steps are needed 
to remove impurities after RuBisCO extraction. For instance, Warren et al. (2000) reported that 
the polyphenol impurities observed in a RuBisCO extract was effectively removed using 
insoluble polyvinylpolypyrrolidone. When used, optimization of purification steps is important 
to avoid protein adsorption onto the separating material in order to maximize protein recovery 
and yield. 
The methods and technologies used in plant protein extractions are usually optimizations of 
decades-old procedures. Interestingly, Chibnall (1939) published a simple but effective protocol 
for extracting proteins via pre-soaking of intact leaves in ethyl acetate followed by repeated 
cycles of soaking in water and then squeezing. The solvent treatment affords changes in the 
semi-permeability of the cell membranes and allows the selective removal of soluble low 
molecular weight non-protein nitrogenous compounds. The plant proteins are then extracted 
using standard extraction techniques following maceration of the leaves (Chibnall, 1939; 
Wildman, 2002). This technique improves the extraction efficiency of plant leaf proteins and 
makes the downstream purification less laborious. This method can be useful for supplying 
RuBisCO material but the use of organic solvents may limit its application in food. Moreover, 
Kim et al. (2013) recently reported the use of protamine sulphate for RuBisCO precipitation 
from soybean leaves. This method effectively extracts both subunits of RuBisCO in a fast, 
simple and economical process. Kobbi et al. (2017) also fractionated RuBisCO from 
industry-generated alfalfa green juice at about 90% purity using ammonium hydroxide and 
sodium hydroxide extraction followed by precipitation at pH 3. Tenorio et al. (2017) also 
combined solvent extraction and Triton X-114 phase partitioning for protein extraction from 
9 
 
sugar beet leaves leading to enhanced protein purity and selective fractionation (Angelica 
Tamayo Tenorio, Boom, & Goot, 2017). Moreover, differential solubility of RuBisCO subunits 
at low pH has facilitated the separation of the subunits and recovery of 48% of the small subunit 
at 98% purity (Trovaslet et al., 2007). These methods can easily be adapted for a wide 
applicability in extracting RuBisCO from leaves of other plants such as Arabidopsis, rice, alfalfa 
and maize. 
Protein yield or recovery is a key factor in assessing the efficiency of an extraction method 
from different sources. Plants generally produce low levels of protein and this is one drawback in 
the adoption of molecular farming as an alternative to animal-based or microbial protein 
production (Sabalza et al., 2014). Obtaining high protein yields during scale up is a major goal of 
the industry and this is attainable during upstream production or downstream processing. The 
latter is a critical part of the process, and the most expensive for recombinant protein processes 
with estimated cost of 57% of the total production cost when using the bioreactor approach 
(Wilken & Nikolov, 2012). Downstream processing is the recovery of highly purified proteins 
from plant matrices (Łojewska, Kowalczyk, Olejniczak, & Sakowicz, 2016), some of which are 
considered plant wastes and “undesirable” for food applications. Recently, Dotsenko and Lange 
(2017) achieved 95% protein recovery (with RuBisCO as the major protein) with consecutive 
protease and carbohydrase treatments from 400 mg each of white clover and ryegrass screw 
press pulp biomass, compared to 40% and 80% protein recoveries with aqueous extraction (pH 
8.0) and protease only treatment, respectively. Furthermore, thermal precipitation or heat 
coagulation has been used to separate soluble and insoluble leaf proteins from plant materials, 
with high yields of RuBisCO recovered in the soluble fraction (Tenorio, Gieteling, De Jong, 
Boom, & Van Der Goot, 2016; van de Velde, Alting, & Pouvreau, 2011b). In one instance, the 
process involves mechanical disruption of 40-80 wt.% of plant leaf materials for cell lysis, 
pressing and centrifugation to recover the juice, heating at 50-80°C to coagulate green proteins, 
and chlorophyll and carotene removal using activated carbon (van de Velde et al., 2011b). These 
steps resulted in the recovery of a powder containing >90% undenatured RuBisCO and <0.1% 
10 
 
chlorophyll from 50-1,000 kg plant leaf dry matter (batch process) or 50-2,000 kg dry matter/h 
(continuous process); the protein recovery and purity varied with different amounts of starting 
materials and processing conditions used (van de Velde et al., 2011b). Therefore, the methods 
still need to be optimized for industrial application to enhance the extraction and high yield 
recovery of RuBisCO especially from neglected and underutilized plant leaf materials. 
 
5. Biological activities of RuBisCO-derived peptides 
5.1. Antihypertensive properties 
Food protein-derived peptides have been widely explored for their antihypertensive properties. 
Antihypertensive peptides play important role in regulating blood pressure mostly through the 
renin-angiotensin system (RAS) and the kinin-nitric oxide system pathways (Udenigwe & Aluko, 
2012). In RAS, angiotensinogen is converted to angiotensin (Ang) I by renin, and Ang I is then 
converted to Ang II by angiotensin I-converting enzyme (ACE). High vascular concentration of 
Ang II, which regulates blood pressure, can lead to excessive blood vessel contraction resulting 
in high blood pressure. Therefore, inhibition of the enzymatic activities of renin and ACE can 
regulate Ang II production and lead to blood pressure lowering effects during hypertension. 
Moreover, in kinin-nitric oxide system, bradykinin induces the release of intracellular calcium 
that activates endothelial nitric oxide synthase, which catalyzes the production of nitric oxide, a 
potent vasodilator (Bjornstad-Ostensen & Berg, 1994). ACE degrades bradykinin and, as such, 
excessive enzyme activity will inhibit vasodilation and activate vasoconstriction. 
Antihypertensive peptides execute their physiological activity partly by inhibiting ACE activity. 
Peptides derived from enzymatic hydrolysis of RuBisCO have shown antihypertensive 
properties by inhibiting the in vitro activity of ACE and lowering blood pressure in hypertensive 
animals. For instance, hydrolysates of alfalfa white protein concentrates (containing 65% 
RuBisCO) treated with Delvolase® (DSM Food Specialties, Seclin, France), a protease 
preparation obtained from Bacillus licheniformis, inhibited ACE activity in vitro with 
half-maximal inhibitory concentration (IC50) value of 8.8 µg/mL (Kapel, Chabeau, et al., 2006). 
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Oral administration of 500 mg/kg body weight of the crude hydrolysate lowered the systolic 
blood pressure of spontaneously hypertensive rats (SHR) by 29.9 mmHg at 4 h (Kapel, Chabeau, 
et al., 2006). Fractionation of the hydrolysate resulted in the identification of a dipeptide VW as 
a major active compound (Kapel, Chabeau, et al., 2006). VW had earlier been found to lower the 
systolic blood pressure of SHR by 10.8 mmHg after 2 h of orally administering the peptide at 7.5 
mg/kg body weight (Marczak et al., 2003). This dipeptide is present in alfalfa RuBisCO large 
subunit at positions f67-68, f382-383 and f459-460, and in the small subunit at f60-61. Apart 
from the bacterial enzyme, pepsin and a combination of pepsin-pancreatin produced most of the 
known RuBisCO hydrolysates and released peptides that exhibited ACE inhibitory activities. 
Notably, some of the peptides discovered from spinach RuBisCO hydrolysates, including large 
subunit-derived peptides MRWRD (f210-214), MRW (rubimetide, f210-212) and LRIPVA 
(f136-141), and small subunit-derived peptide IAYKPAG (f116-122), inhibited ACE activity 
with IC50 values of 2.1, 0.6, 0.38 and 4.2 µM, respectively (Yang, Marczak, Yokoo, Usui, & 
Yoshikawa, 2003). Peptides MRW, MRWRD (both at 30 mg/kg body weight) and IAYKPAG 
(at 100 mg/kg body weight) were also found to lower systolic blood pressure of SHR by 20, 13.5 
and 15 mmHg, respectively (LRIPVA was inactive in vivo), at 2 or 4 h post oral administration 
(Yang et al., 2003). These activities can be partly due to ACE inhibitory activities of the peptides 
in the vascular endothelium of the rats, assuming they were orally bioavailable in their native 
forms. On the other hand, using isolated rat mesenteric artery, it was demonstrated that the 
hypotensive and vasorelaxing activity of peptide MRW are also mediated by endothelin-derived 
factor other than nitric oxide, rather than only ACE inhibition. This effect was found to be 
mediated by prostaglandin D2 (PGD2) and its (DP1) receptor (Zhao, Usui, Ohinata, & Yoshikawa, 
2008). This biological property would be important in managing hypertension associated with 
vascular dysfunction and metabolic diseases. 
Regardless of the blood pressure lowering mechanism, the ACE-inhibiting RuBisCO 
peptides mostly need to be transported across both apical and basolateral sides of the intestinal 
cell barrier and be bioavailable in adequate amounts in the vascular system in order to exert their 
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blood pressure-lowering activities. Moreover, certain gut microbes have impact on the blood 
pressure and vascular function of animal models of hypertension (Jose & Raj, 2015; Karbach et 
al., 2016). Therefore, it is possible that the peptides will interact with the microbiota to regulate 
blood pressure without being absorbed into blood circulation. Since the peptides are generated 
with gastrointestinal proteases, it is likely that the antihypertensive and possibly other bioactive 
peptides are also produced during normal consumption and gut processing of RuBisCO from 
diets containing green vegetables. 
 
5.2. Opioid properties of RuBisCO peptides 
Opioid receptors are specialized G protein-coupled receptors found in the central and peripheral 
nervous, immune and endocrine systems. These receptors bind to specific ligands to regulate 
various biological processes, which can induce anti-nociceptive and anxiolytic activities, as well 
as respiratory depression and gastrointestinal motility reduction (Teschemacher, 2003). Certain 
food protein-derived peptides are known to be opioid receptor ligands and, thus, can trigger some 
of the aforementioned biological effects (Korhonen & Pihlanto, 2006; Teschemacher, 2003; 
Teschemacher, Koch, & Brantl, 1997). Opioid peptides also participate in the absorption 
processes in the gut by modulating gastrointestinal functions such as smooth muscle contraction 
and intestinal transport of electrolytes (Korhonen & Pihlanto, 2006; Teschemacher, 2003). 
Opioid activity of peptides may be agonistic or antagonistic and RuBisCO has been highlighted 
as a food protein source of opioid peptides (Teschemacher, 2003; Perlikowska & Janecka, 2017). 
In fact, antihypertensive activity of alfalfa white protein (RuBisCO-rich) hydrolysate was 
proposed to be partly due to its opioid receptor-binding mechanism based on the loss of its 
relaxant effect in the presence of an opioid receptor antagonist in isolated rabbit ileum (Kapel, 
Chabeau, et al., 2006).  
Moreover, rubiscolin-6 (YPLDLF) derived from spinach RuBisCO (f101-106, large subunit) 
independently exhibited anxiolytic effect mediated by σ1 and dopamine D1 receptors (Yang et al., 
2001; Hirata et al., 2007). To exert this activity, rubiscolin-6 first binds to δ-opioid receptor 
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resulting in the activation of σ1 receptor-dependent mechanism, which releases dopamine and 
stimulates D1 receptors to mediate anxiolytic-like activity (Hirata et al., 2007). Both spinach 
RuBisCO-derived rubisconlin-5 (YPLDL, f101-105, large subunit) and rubiscolin-6 contain the 
sequence YPL. Opioid peptides typically have the YPX sequence where X is an aromatic amino 
acid, e.g. bovine β-casomorphin-8 (YPFPGPIP). Therefore, the substitution of X with an 
aliphatic amino acid, as found in the RuBisCO-derived peptides, did not lead to loss of opioid 
activity (Yang et al., 2001). In a later study, the following modifications of rubiscolin-6: 
Leu3→Ile or Met, Phe6→Val, and combined Leu3→Met/ Phe6→Val was found to increase 
opioid activity by 4, 10 and 20 times, respectively, when evaluated using the mouse vas deferens 
assay (Yang, Sonoda, Chen, & Yoshikawa, 2003). The peptide resulting from the latter 
modification, YPMDLV, showed the lowest binding activity to δ-opioid receptor (IC50 0.12 µM) 
and anti-nociceptive activity in ddY mice when compared to the original rubiscolin-6 (Yang, 
Sonoda, et al., 2003). This demonstrates the importance of amino acid residues at positions 3 and 
6 in the peptide activity. 
Rubiscolin-6 from spinach RuBisCO also effectively enhanced memory consolidation in 
mice, an activity that was also blocked by the δ-opioid receptor antagonist (Yang, Kawamura, & 
Yoshikawa, 2003). Recently, antihypertensive rubimetide from spinach RuBisCO was also found 
to exhibit its anxiolytic effect in ddY mice through the binding of formyl peptide receptor 
(FPR)2, which induces various biological processes, and the PGD2-DP1 receptor, adenosine and 
its A2A receptor, as well as the γ-aminobutyric acid (GABA)-GABAA receptor process (Zhao, 
Sonada, Yoshikawa, Yoshikawa, & Ohinata, 2016). Evidence of in vivo effects in these studies 
demonstrates that the peptides or their derivatives are bioavailable to exert opioid-like 
physiological effects in the animals, and underscores the need for further characterization of the 
peptide release in the gut during RuBisCO digestion, their physiological distribution and 
molecular interactions with the nervous system. 
 
5.3. Food intake-stimulating activity of RuBisCO peptides 
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Peptide hormones such as gastrin and cholecystokinins are involved in stimulating the release of 
digestive enzymes in the gut. These secretagogue molecules are important in controlling food 
intake and appetite control. Using serum gastrin radioimmunoassay, a 1-1.85 kDa peptide 
fraction derived from pepsin hydrolyzed small alfalfa RuBisCO subunit demonstrated 
secretagogue activity at 14.2 pg gastrin equivalent/mg dry mass, which was 8.5 times higher than 
the activity of the crude hydrolysate (Trovaslet et al., 2007). Moreover, rubiscolin-6 was found to 
stimulate increased food intake in mice in a process that was proposed to be mediated by 
lipocallin-type prostaglandin D synthase, DP1 and neuropeptide Y receptor Y1 (Kaneko et al., 
2012). Interestingly, feeding the hexapeptide to 27-month old (aged) mice stimulated more food 
intake compared to observation with similar treatment in younger (15-month old) mice 
(Miyazaki et al., 2014). This indicates the need to further evaluate the potential of the RuBisCO 
peptide for improving food intake and reducing the incidence of “anorexia of aging” and 
associated undernutrition in the elderly. 
 
5.4. Antioxidative properties of RuBisCO peptides 
Free radicals and reactive oxygen species (ROS), produced during metabolic processes and 
oxidative stress, are deleterious to cells and tissues when present in excess amounts. Excessive 
generation of ROS results in oxidative damage of biological macromolecules such as lipids, 
proteins and DNA leading to several complications and health conditions (Betteridge, 2000). 
These damages can be curtailed by adequate supply of exogenous antioxidants in the diet, which 
can complement the cellular antioxidant machinery. Food-derived peptides have been 
extensively investigated for their antioxidative properties in vitro, in cell cultures and in animal 
models (Samaranayaka & Li-Chan, 2011). Enzymatic hydrolysates of RuBisCO (90% purity) 
showed strong in vitro antioxidative capacity by dose-dependently inhibiting linoleic acid 
oxidation, reducing ferric ion, and scavenging a radical cation (Kobbi et al., 2017). Moreover, 
Bondu et al. (2015) reported that a majority (about 60%) of peptides identified in antioxidative 
hydrolysate fractions of red seaweed, Solieria chordalis, were derived from RuBisCO. As with 
15 
 
most antioxidant peptides, there is a dearth of detailed structural and molecular explanations of 
the basis for these bioactivities. This is a particularly important consideration as RuBisCO 
subunits have low amounts of electron-donating (reducing) amino acids such as cysteine (Table 
1). However, the protein subunits have about 5.3% phenylalanine residues that, if present in 
fractionated peptides, can trap ROS and free radicals to form stable hydroxytyrosine derivatives. 
In fact, our recent study identified a possibly antioxidative dipeptide (FC) from in silico analysis 
of plant and microalgae RuBisCO large subunits (f220-221) based on a predictive score and also 
the presence of both phenylalanine and cysteine residues in the structure (Je, Cho, Gong, & 
Udenigwe, 2015). As expected, FC was found to suppress cellular ROS formation and lipid 
peroxidation with increased antioxidative catalase and superoxide dismutase 1 expression in 
oxidative-stressed cultured hepatocytes, as well as increased intracellular glutathione levels in 
normal cells (Je et al., 2015). Similar antioxidative activities would likely be obtained with the 
myriad of peptides generated from RuBisCO hydrolysis by endogenous and exogenous proteases 
considering the diverse structural functionalities and mechanisms of antioxidative peptides. 
Beside health promotion, the RuBisCO peptides can also find important applications in limiting 
oxidative damages that occur during food processing and storage leading to the extension of food 
product stability and shelf life. 
 
5.5. Antibacterial properties of RuBisCO peptides 
Some peptides derived from food proteins also exert antimicrobial activities against pathogenic 
microorganisms (Haque & Chand, 2008) and thereby provide a possible natural alternative to 
synthetic antibiotics. There is emerging evidence on the antimicrobial properties of 
RuBisCO-derived peptides. For instance, high concentrations (up to 30 mg/mL) of 
pepsin-hydrolyzed isolated small RuBisCO subunit and its fraction exhibited partial 
bacteriostatic (and not bactericidal) activity against pathogenic Gram negative bacteria, 
Salmonella arizonae and Shigella sonnei with maximum inhibition zone diameter of about 10 
mm (Trovaslet et al., 2007). This indicates that the active antimicrobial peptides within the 
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fractions may need to be purified to enhance the activity. To support this proposal, RuBisCO 
large subunit-derived peptides ELAAAC (f454-459), LRDDF (f349-353) and MDN (472-474), 
as well as their parent hydrolysate and fractions obtained by hydrolysis of RuBisCO with pepsin 
and purification, were found to exhibit antibacterial activity (Kobbi et al., 2015). The activity 
was observed against Gram negative (Escherichia coli) and Gram positive (Micrococcus luteus, 
Listeria innocus and Bacillus subtilis) bacteria with minimal inhibitory concentrations of 
2.62-5.27 mM. The best effects were exhibited by tripeptide MDN against L. innocum and 
hexapeptide ELAAAC against M. luteus and L. innocum (Kobbi et al., 2015). These peptides 
possess structural features that differ from those of typical cell membrane-disrupting 
amphipathic/cationic antimicrobial peptides, and are therefore expected to display different 
functional mechanisms in the bacteria. The antimicrobial RuBisCO hydrolysates and peptides 
can be relevant in food preservation by limiting microbial growth and associated spoilage, and in 
eliminating food-borne pathogens from the food system. 
 
6. Prospective release of other bioactive peptides from RuBisCO 
Bioinformatics, using web-based tools, is emerging as a useful approach for studying the 
occurrence and biological roles of food peptides (Udenigwe, 2014, Maestri et al., 2016). Using 
this approach, many RuBisCO peptide sequences, previously isolated from other sources, have 
been found to show various bioactivities other than the aforementioned properties (Udenigwe, 
Gong, & Wu, 2013). As shown in Table 3, alfalfa RuBisCO large and small subunits contain 
bioactive peptides that exhibit 12 and 13 different health-related bioactivities, respectively. The 
occurrence frequencies (A) of the peptides in RuBisCO are generally similar or lower than those 
of bovine β-casein, a typical bioactive peptide source, but the RuBisCO proteins are better 
sources of neuropeptides and peptides with ubiquitin-mediated proteolysis activating, bacterial 
permease ligand, and hypotensive activities (Table 3). Notably, the plant RuBisCO subunits have 
high A values for dipeptidyl peptidase (DPP)-IV inhibitors. The A values for this bioactivity are 
an order of magnitude higher than those reported for large RuBisCO subunit from various 
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seaweed (Caulerpa) species (Agirbasli & Cavas, 2017). This observation in our study is due to 
the high content of hydrophobic amino acid residues especially alanine and proline in the plant 
RuBisCO, which play major structural roles for DPP-IV inhibition (Nongonierma & FitzGerald, 
2016). DPP-IV inhibitors are important in preventing the inactivation of incretins and promoting 
insulin secretion and glucose metabolism. However, DPP-IV inhibition is yet to be reported for 
RuBisCO peptides. 
Despite the promising outlook, the bioactivities in Table 3 can only be observed on 
successful release of the peptides from the RuBisCO subunits. Using DPP-IV as an example, 
Table 4 shows the frequency of release of peptides with DPP-IV inhibitory activity by selected 
proteases (AE) and the relative frequency of release of fragments with the bioactivity by each 
protease (W), as proposed by Minkiewicz et al. (2008). When classified based on functional 
mechanisms, cysteine proteases (ficin and papain) and metalloprotease (thermolysin) released 
more DPP-IV inhibiting peptides from the alfalfa large RuBisCO subunit when compared to 
serine (chymotrypsin A, trypsin) and aspartate proteases (pepsin). The results are similar or 
better than the release of these peptides, by same proteases, from bovine β-casein. This is likely 
due to the preference of ficin, papain and thermolysin in cleaving peptide bond of proteins near 
hydrophobic amino acid residues, which are needed for potent DPP-IV inhibition. Conversely, 
ficin and chymotrypsin A are better in releasing DPP-IV inhibitors from the small RuBisCO 
subunit (Table 4). These possibilities, if confirmed experimentally, will expand the relevance of 
RuBisCO-derived peptides as functional ingredients for multiple health and food applications. 
 
7. Fractionation and recovery of RuBisCO peptides  
During hydrolysis of RuBisCO, it is important to optimize parameters such as reaction 
temperature, duration, pH, ionic strength, enzyme-substrate ratio, and use of single or multiple 
enzymes. This will ensure the production of high yields of particular peptides with the desired 
bioactivity. For instance, pepsin released 0.17% mol rubiscolin-5 per mol RuBisCO large subunit, 
but further hydrolysis with leucine aminopeptidase increased the peptide yield by 29 folds to 5% 
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mol (Yang et al., 2001). After hydrolysis, bioactive peptides can be left in the complex 
hydrolysate matrix for use in food product formulation. However, matrix interactions may lead 
to low abundance of peptides of interest, which can minimize their bioactivity within the 
hydrolysate (Udenigwe & Fogliano, 2017). In such cases, bioactive peptides often need to be 
recovered by fractionation and purification prior to structural characterization and bioactivity 
evaluation. Bioactive peptides have been fractionated from hydrolysates by solid-phase 
extraction and chromatographic techniques (size exclusion, ion exchange, reversed-phase) based 
on molecular size, charge and hydrophobicity (Chen, Mant, & Hodges, 2007; Hayes, Ross, 
Fitzgerald, Hill, & Stanton, 2006; Udenigwe & Aluko, 2012). Membrane chromatography 
involving the use of ligand-bound membranes has also been used for the purification of small 
proteins and peptides based on ion-exchange and hydrophobic interaction principles (Saxena, 
Tripathi, Kumar, & Shahi, 2009). 
Bioactive peptides derived from RuBisCO have been purified from their parent hydrolysates 
mostly by size exclusion and reverse-phase high performance liquid chromatography (Kapel, 
Chabeau, et al., 2006; Kapel, Rahhou, Lecouturier, Guillochon, & Dhulster, 2006; Kobbi et al., 
2015, 2017; Trovaslet et al., 2007; Yang et al., 2003). Although these purification steps lead to 
relatively pure peptides, scale up of the processes for industrial application is currently not 
feasible due to high cost and complex analytical set-ups involved. Simpler methods have also 
been explored as cheaper alternatives. For instance, an antimicrobial peptide fraction was 
separated from RuBisCO hydrolysate by precipitation under ionic strength and pH effect, which 
involves adding NaCl and adjusting the hydrolysate solution to neutral pH to precipitate the 
peptides (Kobbi et al., 2015). However, liquid chromatography was later used to obtain more 
purified peptides from the fraction. Electrodialysis coupled with membrane ultrafiltration (EDUF) 
is another technique used to recover the antihypertensive dipeptide VW from alfalfa white 
protein (RuBisCO) hydrolysate with high transmission rates using a semi-pilot process that can 
be translated in the industry (Firdaous et al., 2009, 2010). Furthermore, VW was also 
fractionated from a similar hydrolysate with 97% recovery (30.7 mg, 10.9% purity from 1 g of 
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hydrolysate) using a mixed ion-exchange centrifugal partition chromatography on a quaternary 
biphasic solvent system and a lipophilic cationic exchange column (Boudesocque et al., 2012). 
These processes are promising but the peptide extraction still needs to be scaled up industrially 
to obtain larger quantities with high purity. Recently, perfusion chromatography with the use of 
monolithic columns was proposed as a cost-effective and scalable strategy for the purification of 
bioactive peptides (Agyei, Ongkudon, Wei, Chan, & Danquah, 2016). This technique can be 
explored for obtaining large amounts of purified RuBisCO peptides. 
 
8. Conclusion and future direction 
RuBisCO remains the most abundant protein on earth and has been explored as a sustainable 
source of bioactive peptides. This is supported by in vitro and in vivo evidence of bioactivities of 
RuBisCO-derived peptides, and by information derived from in silico predictions. Extraction 
efficiency and recovery of high yields are major determinants of industrial utilization of protein 
isolates in developing food products. Therefore, efforts should be directed towards obtaining 
more efficient, green extraction and recovery technologies to scale up industrial production of 
RuBisCO isolates, especially from non-traditional sources such as plants that are not commonly 
consumed as food, neglected and underutilized crops, and vegetable food wastes. This support 
the maximum use of renewable natural resources, sustainability and bioeconomy development at 
the local and global levels. Although RuBisCO-derived peptides have been evaluated for health 
promotion and disease prevention, the protein also has potential for use as a functional ingredient 
in various other food applications. It is also likely that RuBisCO peptides generated during 
gastrointestinal food digestion contribute to some known health benefits associated with 
vegetable consumption. Furthermore, human studies need to be conducted to substantiate the 
aforementioned preclinical bioactivities of RuBisCO peptides. On a long-term basis, the use of 
leaves from non-traditional food sources as a reliable source of RuBisCO needs substantial 
research investment in order to limit competition with food crops. The expected end goal is the 
sustainable production of RuBisCO, its conversion into bioactive peptides, and translation of the 
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peptides into marketable functional foods for use in prevention and management of health 
conditions. 
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FIGURES 
Fig. 1. Structure of activated unliganded spinach RuBisCO; Large chain, green ribbons; 
Small chain, blue ribbons. PDB file: 1AUS; DOI: 10.2210/pdb1aus/pdb; Primary reference 
(Taylor & Andersson, 1997). 
 
Fig. 2. Simplified schematic for the extraction of plant RuBisCO and production of RuBisCO 
hydrolysates and peptides 
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TABLE 1. AMINO ACID COMPOSITION AND PROPERTIES OF ALFALFA 
RUBISCO LARGE AND SMALL SUBUNITS CALCULATED WITH UNIPROTKB 
PROTPARAM. 
 
 Large subunit  Small subunit 
No. of 
AA 
% No. of AA % 
Ala 48 10.2  5 4.1 
Arg 30 6.4  7 5.7 
Asn 15 3.2  3 2.4 
Asp 27 5.7  5 4.1 
Cys 8 1.7  3 2.4 
Gln 12 2.5  5 4.1 
Glu 33 7.0  11 8.9 
Gly 45 9.5  7 5.7 
His 14 3.0  2 1.6 
Ile 21 4.4  7 5.7 
Leu 39 8.3  11 8.9 
Lys 23 4.9  9 7.3 
Met 10 2.1  2 1.6 
Phe 23 4.9  7 5.7 
Pro 21 4.4  9 7.3 
28 
 
Ser 14 3.0  6 4.9 
Thr 31 6.6  5 4.1 
Trp 8 1.7  4 3.3 
Tyr 17 3.6  8 6.5 
Val 33 7.0  7 5.7 
No. of AA 472  123 
pI 6.10  6.73 
MW (Da) 52,407  14,557 
GRAVY -0.247  -0.438 
AA, amino acid; pI, theoretical isoelectric point; MW, 
molecular weight; GRAVY, grand average of 
hydropathicity 
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TABLE 2. BIOACTIVE PEPTIDES DERIVED FROM PLANT RUBISCO. 1 
 2 
Sequence Subunit Source Location Protease  Fractionation Bioactivity summary Reference 
MRWRD Large Spinach 210-214 Pepsin + 
pancreatin 
RP-HPLC + 
purification on 
phenethyl silica, 
cyanopropyl silica & 
nitrophenetyl columns 
ACE inhibition & SBP 
lowering in hypertensive 
rats (except LRIPVA); 
Opioid activity (MRW) 
Yang et al., 2003 
Zhao et al., 2016 
MRW 
(rubimetide) 
Large 210-212  
LRIPVA Large 136-141 
IAYKPAG Small 116-122 
YPLDL 
(rubiscolin-5) 
Large Spinach 101-105 Pepsin + leucine 
aminopeptidase 
RP-HPLC + 
purification on 
phenethyl silica 
column; Also 
synthesized 
Opioid & anxiolytic 
activities; Food intake 
stimulation (rubiscolin-6) 
Hirata et al., 2007 
Yang et al., 2001, 
2003b,c 
Miyazaki et al., 2014 
 
YPLDLF 
(rubiscolin-6) 
Large 101-106 
VW Large 
 
Small 
Alfalfa 67-68, 
382-383, 
459-460 
61-61 
Delvolase Size-exclusion + 
RP-HPLC; 
Electrodialysis with 
ultrafiltration 
ACE inhibition & SBP 
lowering in hypertensive 
rats 
Kapel et al., 2006a,b 
Marczak et al., 2003  
Firdaous et al., 2009, 
2010 
ELAAAC Large Alfalfa 454-459 Pepsin RP-HPLC + 
precipitation under 
ionic & pH effects 
Antibacterial activity 
against Escherichia coli, 
Micrococcus luteus, Listeria 
innocus & Bacillus subtilis 
Kobbi et al., 2015 
LRDDF Large 349-353 Pepsin 
MDN Large 472-474 Pepsin 
FC Large Various plant 
sources 
220-221 Thermolysin 
(prediction 
only) 
Synthesized Antioxidant activity in 
hepatic cell culture treated 
with an oxidant 
Je et al., 2015 
RP-HPLC, reverse phase-high performance liquid chromatography; ACE, angiotensin I-converting enzyme; SBP, systolic blood pressure 
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 3 
TABLE 3. FREQUENCY OF OCCURRENCE OF BIOACTIVE  4 
PEPTIDES IN THE LARGE AND SMALL SUBUNITS OF  5 
ALFALFA RUBISCO COMPARED TO BOVINE β-CASEIN. 6 
 7 
 
Bioactivity 
A
a
 
Large 
subunit 
Small 
subunit 
Bovine 
β-Casein 
ACE inhibitor 0.4788  0.4472  0.6555  
Anorectic n/a n/a 0.0048  
Activating ubiquitin-mediated proteolysis 0.0191  0.0163  n/a 
Antiamnestic 0.0085  0.0081  0.0478  
Anticancer n/a n/a 0.0191  
Antioxidative 0.0742  0.0813  0.0909  
Antithrombotic 0.0085  0.0081  0.0287  
Bacterial permease ligand n/a 0.0244  0.0048  
Chemotactic n/a n/a 0.0048  
Dipeptidyl peptidase IV inhibitor 0.6441  0.6911  0.8182  
Hypotensive 0.0064  0.0325  0.0048  
Immunomodulating 0.0042  n/a 0.0191  
Immunostimulating n/a n/a 0.0048  
Inhibitor 0.0064  0.0325  0.0048  
Neuropeptide 0.0042  0.0163  n/a 
Opioid n/a 0.0081  0.0144  
Regulating 0.0148  0.0081  0.0287  
Stimulating 0.0339  0.0325  0.0718  
a
A=a/N, where A is the frequency of bioactive fragments occurrence in protein sequence, 
a is the number of fragments with given activity in the protein sequence, and N is the 
number of amino acid residues of the protein. The calculations were done using the 
BIOPEP software at http://www.uwm.edu.pl/biochemia/index.php/en/biopep 
 8 
 9 
 10 
 11 
 12 
 13 
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 14 
TABLE 4. POTENTIAL RELEASE OF DIPEPTIDYL PEPTIDASE IV INHIBITING 15 
PEPTIDES FROM THE LARGE AND SMALL SUBUNITS OF ALFALFA RUBISCO 16 
AFTER ENZYMATIC HYDROLYSIS. 17 
 18 
 Large subunit
a
 Small subunit
a
 Bovine β-Caseina 
AE
b 
W
c
 AE W AE W 
Cysteine proteases 
Bromelain 0.0360  0.0559  0.0163  0.0236 0.0144  0.0176  
Ficin 0.0636  0.0987  0.0569  0.0823 0.0813  0.0994 
Papain 0.0699  0.1085 0.0325  0.0470  0.0239  0.0292 
Serine proteases 
Chymotrypsin A 0.0191  0.0297  0.0407  0.0589 0.0335  0.0409 
Trypsin 0.0106  0.0165  0.0081  0.0117 0.0048  0.0059 
Aspartate protease 
Pepsin 0.0106  0.0165 0.0163  0.0236 0.0239  0.0292 
Metalloprotease 
Thermolysin 0.0614  0.0953 0.0244  0.0353 0.0526  0.0643 
a
UniProtKB accession numbers P04991 for alfalfa RuBisCO large subunit, O65194 for alfalfa 
RuBisCO small subunit, and P02666 for bovine β-casein. 
b
AE=d/N, where AE is the frequency of release of fragments with given activity by the selected enzyme, 
d is the number of peptides with given activity released by given enzyme, and N is the number of 
amino acid residues in the protein (Minkiewicz et al., 2008). 
c
W= AE/A, where W is the relative frequency of release of fragments with given activity by selected 
enzyme, and A is the frequency of bioactive fragments occurrence in protein sequence (Minkiewicz et 
al., 2008). The calculations were done using the BIOPEP software at 
http://www.uwm.edu.pl/biochemia/index.php/en/biopep 
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Fig. 1. 31 
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Fig. 2. 64 
 65 
Plant leaves 
Purification and polishing using 
adsorption and chromatographic 
techniques 
Fractionation and purification of 
RuBisCO hydrolysates and peptides 
(using chromatographic and 
electrodialysis with ultrafiltration 
membrane techniques) 
Enzymatic hydrolysis 
Optional treatment step to 
remove pigments and other 
non-protein nitrogenous 
compounds 
 Maceration and buffer extraction 
Selective precipitation of RuBisCO 
proteins 
